HCAT vs PHR
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
HCAT
PHR
Investment Advisor Scores
PHR
AI Analyst Insights
Detailed Metrics Comparison
| Metric | HCAT | PHR | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 10 | 14.4928 | HCAT |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -26.3% | 10.4% | PHR |
| Earnings Growth | 0.0% | 200.0% | PHR |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 51.6/100 | 40.2/100 | HCAT |
| Profit Margin | -74.2% | 2.1% | PHR |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
HCAT
MarkdownPrice below a falling SMA50 (slope -2.6%), weak momentum, RSI 37
PHR
MarkupPrice above SMA50, rising 50-day trend (1.4% over 20 days), RSI 60
Fundamentals Snapshot
| Metric | HCAT | PHR |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -572.0 | 8.5 |
| Trailing P/E | — | 77.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.3% | 0.1% |
| Gross Margin | 0.5% | 0.7% |
| Operating Margin | -0.2% | 0.1% |
| EPS | -2.80 | 0.17 |
| Dividend Yield | — | — |